title: Can proteomics lead to the discovery of real biomarkers for HCC?
abstract: The development of proteomics technologies has lead to a great deal of effort being focused on the identification of biomarkers for cancers. Although many papers have reported candidate biomarkers for hepatocellular carcinomas (HCCs) in particular, so far none of these candidate biomarkers have been used either for diagnosis or therapy intreating patients. The question remains: Can proteomics identify real biomarkers for HCCs?
authors.affiliation: Yasuhiro Kuramitsu, Yamaguchi University Graduate School of Medicine, Department of Biochemistry and Functional Proteomics, 1-1-1 Minami-kogushi, Ube, Yamaguchi 755-8505, Japan.
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Kuramitsu